Aim and Strategy
The aims of the study group are:
- To perform clinical studies to assess normal and abnormal circulatory physiology and growth of the fetus and consequences for perinatal outcome and postnatal development of health and disease. We use ultrasound techniques, fetal ECG, anthropometric measurements and measurements of physical activity, biochemical and genetic techniques as well as interviews and focus in particular placental function, fetal growth regulation, body composition and growth deviation, underlying cardiovascular mechanisms and diagnostic possibilities in addition to specific fetal cardiovascular diseases. Biobanks are established correspondingly and a collaboration network of pediatricians, biologists, pathologists and other professionals.
- To perform clinical research on fetal heart rate physiology during pregnancy and fetal monitoring during labor. ECG based transabdominal fetal Holter technology and ST analysis of the fetal ECG are used to assess low- and high-risk pregnancies.
- To conduct epidemiological studies, including longitudinal family studies based on the Medical birth registry and the Norwegian Mother and Child Cohort Study, the focus being pregnancy complications such as preeclampsia, growth deviation placental abruption and delivery methods. Family studies include study of recurrence of these complications following the same mother or father, recurrence between siblings and other family members and intergenerational recurrence. The studies are commonly expanded to the Central Population Registry of Norway, which provides almost complete population data with links between parents and relatives.